Skip to main content
. 2015 Jun 30;10:18. doi: 10.1186/s13027-015-0013-1

Table 2.

Viral risk factors in the 30 patients with HCC

Serological and molecular features n (%)
HBsAg(+) 19 (63.3)
HBeAg(+) 5 (16.6)
anti-HBc(+) 28 (92.5)
anti-hepatitis B immunization 3 (10.0)
anti-HCV (+) 14 (46.6)
Co-infection HBsAg(+)/anti-HCV(+) 8 (26.6)
HBV DNA (+) 14 (46.6)
Genotype E 14/14 (100.0)

n represents the number of positive samples. Percentages are given for the 30 patients except for HBV genotype